11248
J. Am. Chem. Soc. 2000, 122, 11248-11249
Scheme 1. Synthesis of the Putative Aeruginosin 298-A (1a)a
Total Synthesis and Reassignment of Configuration
of Aeruginosin 298-A
Nativitat Valls, Meritxell Lo´pez-Canet, Merce` Vallribera, and
Josep Bonjoch*
Laboratory of Organic Chemistry, Faculty of Pharmacy
UniVersity of Barcelona, 08028-Barcelona, Spain
ReceiVed June 28, 2000
Aeruginosin 298-A (1) is a peptidic active-site protease inhibitor
containing nonstandard amino acids produced by a blue-green
alga, reported for the first time in 1994,1 whose structural
elucidation was not effected until 1998.2 At that time, the X-ray
crystallographic structure of the ternary complex of 298-A bound
to hirugen-thrombin was reported, revealing several unexpected
interactions that may be useful and of importance for structure-
based drug design.
The structure 1a depicted in Figure 1 was assigned to
aeruginosin 298-A in which the core ring consisting of a
2-carboxy-6-hydroxyoctahydroindole (choi) is unprecedented
among natural or synthetic products. Until now, fourteen members
of the aeruginosin family have been identified,3,4 all of which
share the aforementioned new bicyclic R-amino acid choi or a
closely related derivative.5
a Reagents and conditions: (i) Li, NH3, THF-tBuOH (2.5:1), -78 °C;
(ii) MeOH-7.5 N HCl, 35 °C, 48 h; (iii) BnBr, NaHCO3, EtOH, 70 °C,
6 h; (iv) MeOH-8 N HCl, 65 °C, 17 h (44% from 2), (v), H2, Pd(OH)2
20%, Boc2O, EtOAc, room temperature, 48 h, 79%, (vi) LS-selectride
(1 M in THF, 1.3 equiv), THF, -78 °C, 53% for isomer 9, (vii) TFA,
CH2Cl2, 0 °C, 45 min; (viii) Boc-L-Leu, BOP, NMM, CH2Cl2, 0 °C, 30
min, then room temperature, 22 h, 43% from 9; (ix) TFA, CH2Cl2, 0 °C,
45 min; (x) 12, BOP, NMM, CH2Cl2, 0 °C, 30 min, then room
temperature, 18 h, 60% from 11; (xi) 0.1 N LiOH, THF, room
temperature, 20 h, 92%; (xii) L-Arg(NO2)OMe.HCl, BOP, NMM, DMF,
0 °C, 30 min, then room temperature, 24 h 46%; (xiii) LiBH4 (2 M in
THF), THF, room temperature, 3 h, 50%; (xiv) H2, Pd-C 10%, EtOAc-
MeOH, 6 N HCl, 1 atm, room temperature, 8 h, 70%.
Figure 1. Configuration at *S putative aeruginosin 298-A (1a) and
configuration at *R Aeruginosin 298-A (1b).
In this paper, we described the first total synthesis of aerugi-
nosin 298-A and in turn clarify its configuration, since we also
report that structure 1a does not correspond to natural aeruginosin
298-A. We give synthetic evidence that compound 1b, incorporat-
ing a D-Leu (not L-Leu), corresponds to the natural structure. The
strategy we have developed for assembling the four units of the
peptide involves the construction of an appropriately function-
alized and stereochemically pure octahydroindole (choi core) and
the coupling with the other fragments.
Initially, we synthesized the putative aeruginosin 298-A (1a).
The starting material for our synthesis was the protected L-tyrosine
2, which was submitted to the Birch reduction conditions followed
by treatment of the resulting dihydroanisole 3 with a methanol
solution of hydrogen chloride to give a mixture of octahydroindol-
6-ones,6 which were benzylated to furnish a diastereomeric
mixture of exo and endo isomers in a 1.8:1 ratio. After
chromatographic separation of both isomers, the exo isomer 4
was transformed to the desired isomer endo 5 by warming in
methanol containing hydrogen chloride, taking advantage of the
â-amino ketone moiety. The equilibration process took place in
more than 90% of extension in favor of the endo isomer. After
these operations octahydroindolone 5 with the adequate relation-
ship between its three stereocenters was available in multigrams
amounts, the overall yield for these four initial steps being 44%.
To achieve the functionalization and stereochemistry adequate
at C-6, ketone 5 was subjected to reduction under several
conditions, but in all cases the undesired isomer 6 was the major
product irrespective of the hydride used (i.e. NaBH4 or LS-
selectride). This fact is probably due to the conformation of
(1) Murakami, M.; Okita, Y.; Matsuda, H.; Okino, T.; Yamaguchi, K.
Tetrahedron Lett. 1994, 35, 3129.
(2) Rios Steiner, J. L.; Murakami, M.; Tulinsky, A. J. Am. Chem. Soc.
1998, 120, 597.
(3) (a) Aeruginosins 98-A and B: Murakami, M.; Ishida, K.; Okino, T.;
Okita, Y.; Matsuda, H.; Yamaguchi, K. Tetrahedron Lett. 1995, 36, 2785.
Sandler, B.; Murakami, M.; Clardy, J. J. Am. Chem. Soc. 1998, 120, 596. (b)
Aeruginosins 102-A and B: Matsuda, H.; Okino, T.; Murakami, M.;
Yamaguchi, K. Tetrahedron 1996, 52, 14501 (c) Aeruginosin 103-A: Kodani,
S.; Ishida, K.; Murakami, M. J. Nat. Prod. 1998, 61, 1046. (d) Aeuginosins
89-A and B, 98-C, 101 and 298-B: Ishida, K.; Okita, H.; Matsuda, H.; Okino,
T.; Murakami, M. Tetrahedron 1999, 55, 10971.
(4) Microcin SF608, isolated in the Red Sea, has the same structural
pattern: Banker, R.; Carmeli, S. Tetrahedron 1999, 55, 10835.
(5) Aeruginosins 205-A and 205-B show a 6-chloro substituent in the
octahydroindole ring: Shin, H. J.; Matsuda, H.; Murakami, M.; Yamaguchi,
K. J. Org. Chem. 1997, 62, 1810.
(6) For the use of tyrosine compounds as building blocks for the synthesis
of octahydroindolone derivatives, see: (a) Bonjoch, J.; Catena, J.; Isa´bal, E.;
Lo´pez-Canet, M.; Valls, N. Tetrahedron: Asymmetry 1996, 7, 1899. (b)
Bonjoch, J.; Catena, J.; Terricabras, D.; Ferna`ndez, J.-C.; Lo´pez-Canet, M.;
Valls, N. Tetrahedron: Asymmetry 1997, 8, 3143.
10.1021/ja002341i CCC: $19.00 © 2000 American Chemical Society
Published on Web 11/01/2000